We Stand For Care

Everyone diagnosed with multiple sclerosis lives under a virtual sword of Damocles—continually anxious about when the next debilitating attack on their central nervous system will occur. COMMITTED to raising their profile, Stanford Hospital & Clinics is expanding services to MAKE A DIFFERENCE for the patients being served. Stanford Multiple Sclerosis Center is one of the fastest-growing MS centers in the nation, currently treating more than 600 patients.

“Even when they’re feeling physically well, there’s always an uncertainty about a new attack,” said Jeffrey Dunn, MD, the new associate director of Stanford’s Multiple Sclerosis Center and clinical associate professor of neurology and neurological sciences at the medical school. “One of the best treatments for that uncertainty is the certainty that we will be there for them.”

The Stanford MS Center was recognized in recent months when Stanford was invited to join the national Consortium of Multiple Sclerosis Centers, and also was named one of 10 academic medical centers that are part of the Accelerated Cure Project for Multiple Sclerosis.

The goal of Stanford’s MS program is to offer BETTER MEDICINE and “build a full spectrum of services, from cutting-edge MS research, through translational study, all the way to a robust clinical program,” stated Frank Longo, MD, PhD, professor and chair of neurology and neurological sciences.

“Right now we don’t have a cure—we can’t cut it out by surgery, we can’t eradicate it by antibiotics, we can’t irradiate it like a tumor,” he said. “But we can tell people that early treatment can make a huge difference. And we can promise to walk alongside our patients, keeping close and providing support and encouragement,” stated Dunn.

To learn more about the Stanford MS Center, click here.